ADC THERAPEUTICS SA (ADCT) — insider trading
Health Care · NYSE
ADC THERAPEUTICS SA (ADCT) has 24 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 24 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | MALLIK AMEET | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 675,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Carmona Jose | Officer (Chief Financial Officer) | Grant / award / vesting | 203,700 | $0.00 | $0 | Form 4 |
| 2026-06-30 | GRAHAM PETER J | Officer (Chief Legal Officer) | Grant / award / vesting | 221,100 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Zaki Mohamed | Officer (Chief Medical Officer) | Grant / award / vesting | 213,900 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Coughlin Timothy | Director | Shares withheld for taxes / exercise cost | 12,600 | $3.08 | $38.8K | Form 4 |
| 2026-06-03 | BIZZARI JEAN-PIERRE | Director | Shares withheld for taxes / exercise cost | 12,600 | $3.08 | $38.8K | Form 4 |
| 2026-06-03 | Hug Peter | Director | Shares withheld for taxes / exercise cost | 2,156 | $3.08 | $6.6K | Form 4 |
| 2026-06-03 | Monges Viviane | Director | Shares withheld for taxes / exercise cost | 2,596 | $3.08 | $8.0K | Form 4 |
| 2026-06-03 | Sandor Victor | Director | Shares withheld for taxes / exercise cost | 12,600 | $3.08 | $38.8K | Form 4 |
| 2026-06-03 | Squarer Ron | Director | Shares withheld for taxes / exercise cost | 15,196 | $3.08 | $46.8K | Form 4 |
| 2026-06-03 | Azelby Robert | Director | Shares withheld for taxes / exercise cost | 12,600 | $3.08 | $38.8K | Form 4 |
| 2026-06-01 | Coughlin Timothy | Director | Grant / award / vesting | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-01 | BIZZARI JEAN-PIERRE | Director | Grant / award / vesting | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Hug Peter | Director | Grant / award / vesting | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Monges Viviane | Director | Grant / award / vesting | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Sandor Victor | Director | Grant / award / vesting | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Squarer Ron | Director | Grant / award / vesting | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Azelby Robert | Director | Grant / award / vesting | 45,000 | $0.00 | $0 | Form 4 |
| 2026-04-02 | Redmile Group, LLC; Green Jeremy; RedCo II Master Fund, L.P. | 10% owner | Open-market sale | 2,529,491 | $3.28 | $8.29M | Form 4 |
| 2026-04-02 | Redmile Group, LLC; Green Jeremy; RedCo II Master Fund, L.P. | 10% owner | Open-market sale | 2,634,506 | $3.28 | $8.64M | Form 4 |
| 2026-04-01 | Redmile Group, LLC; Green Jeremy; RedCo II Master Fund, L.P. | 10% owner | Open-market sale | 162,517 | $3.80 | $617.4K | Form 4 |
| 2026-04-01 | Redmile Group, LLC; Green Jeremy; RedCo II Master Fund, L.P. | 10% owner | Open-market sale | 169,265 | $3.80 | $643.0K | Form 4 |
| 2026-03-31 | Redmile Group, LLC; Green Jeremy; RedCo II Master Fund, L.P. | 10% owner | Open-market sale | 188,407 | $3.75 | $706.9K | Form 4 |
| 2026-03-31 | Redmile Group, LLC; Green Jeremy; RedCo II Master Fund, L.P. | 10% owner | Open-market sale | 196,229 | $3.75 | $736.3K | Form 4 |
Ask the chat about ADCT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ADC THERAPEUTICS SA (ADCT).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.